Current Price and Market Context
As of 8 September 2026, Abbott India’s stock closed at ₹25,896.45, down from the previous close of ₹26,071.95. The stock traded within a range of ₹25,775.60 to ₹26,120.00 during the day, remaining closer to its 52-week low of ₹25,164.00 than its high of ₹31,650.00. This price action reflects a cautious market sentiment, especially when compared with the broader Sensex index, which has shown a 1-week decline of 1.07% while Abbott India marginally outperformed with a 0.16% gain over the same period.
Technical Trend and Indicator Analysis
The technical trend for Abbott India has shifted from bearish to mildly bearish, signalling a tentative improvement but still reflecting underlying weakness. The Moving Average Convergence Divergence (MACD) remains bearish on both weekly and monthly charts, indicating that the stock’s momentum is still under pressure. The MACD’s sustained bearishness suggests that the downward momentum has not yet been decisively reversed.
The Relative Strength Index (RSI) on weekly and monthly timeframes currently shows no clear signal, hovering in a neutral zone. This lack of directional RSI momentum implies that the stock is neither overbought nor oversold, which could mean a consolidation phase or indecision among traders.
Bollinger Bands provide further insight, with weekly readings bearish and monthly readings mildly bearish. The stock price is likely trading near the lower band on the weekly chart, signalling potential short-term oversold conditions, but the monthly mildly bearish stance suggests that longer-term volatility remains subdued but negative.
Daily moving averages continue to reflect a bearish trend, reinforcing the short-term downward pressure. However, the Know Sure Thing (KST) indicator presents a mixed picture: bullish on the weekly timeframe but bearish monthly. This divergence indicates that while short-term momentum may be improving, the longer-term trend remains under strain.
Dow Theory analysis shows no clear trend on the weekly chart but a mildly bullish trend on the monthly chart. This suggests that while the immediate price action is uncertain, the broader market forces may be gradually shifting in favour of the stock.
On-Balance Volume (OBV) readings align with this view, showing no trend weekly but a bullish trend monthly. This indicates that buying volume is increasing over the longer term, which could support a potential recovery if sustained.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Comparative Returns and Market Performance
Abbott India’s returns over various timeframes present a nuanced picture when compared with the Sensex. Over the past week, the stock has marginally outperformed the Sensex, gaining 0.16% against the index’s 1.07% decline. However, over the last month, Abbott India has underperformed with a 6.78% loss compared to the Sensex’s 3.01% decline.
Year-to-date (YTD) returns show Abbott India down 10.92%, slightly worse than the Sensex’s 10.66% fall. Over the last year, the stock has declined 16.94%, significantly underperforming the Sensex’s 5.67% loss. This underperformance highlights sector-specific or company-specific challenges that have weighed on the stock.
Longer-term returns are more encouraging. Over three years, Abbott India has delivered a 12.64% gain, slightly below the Sensex’s 14.89%. Over five years, the stock has outperformed marginally with a 31.43% return versus the Sensex’s 30.63%. Most notably, over a decade, Abbott India has delivered a remarkable 465.20% return, vastly exceeding the Sensex’s 163.19% gain, underscoring its strong long-term growth trajectory.
Mojo Score and Rating Upgrade
MarketsMOJO has upgraded Abbott India’s Mojo Grade from Sell to Hold as of 7 September 2026, reflecting a cautious but improved outlook. The current Mojo Score stands at 50.0, indicating a neutral stance. This upgrade is consistent with the technical trend shift from bearish to mildly bearish and the mixed signals from various indicators.
Investment Implications and Outlook
Investors should note that while short-term technical indicators such as the MACD and moving averages remain bearish, there are early signs of momentum stabilisation, particularly in weekly KST and monthly OBV readings. The neutral RSI and mildly bullish Dow Theory monthly trend suggest that the stock may be entering a consolidation phase before a potential recovery.
Given the stock’s mid-cap status and sector dynamics, volatility is expected to persist. The recent downgrade in price and technical caution advises a prudent approach. Investors may consider holding current positions while monitoring for confirmation of trend reversal signals, such as a bullish MACD crossover or sustained RSI improvement above 50.
Abbott India Ltd. or something better? Our SwitchER feature analyzes this mid-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Industry Considerations
Operating within the Pharmaceuticals & Biotechnology sector, Abbott India faces sector-specific headwinds including regulatory scrutiny, pricing pressures, and competitive innovation. These factors contribute to the stock’s technical volatility and mixed momentum signals. However, the company’s long-term fundamentals remain robust, supported by a diversified product portfolio and steady revenue streams.
Mid-cap stocks like Abbott India often experience sharper price swings compared to large caps, which is reflected in the technical indicators’ divergence. The current mildly bearish technical trend suggests that while the stock is not in a strong uptrend, it is also not in freefall, offering a potential entry point for investors with a medium to long-term horizon.
Conclusion
Abbott India Ltd.’s recent technical parameter changes highlight a nuanced shift in price momentum. While bearish signals persist in key indicators such as MACD and moving averages, emerging bullish cues in KST and OBV on longer timeframes suggest a possible stabilisation. The upgrade from Sell to Hold by MarketsMOJO aligns with this cautious optimism.
Investors should weigh the stock’s mixed technical signals against its historical outperformance and sector fundamentals. A watchful approach is recommended, focusing on confirmation of trend reversals before committing to new positions. Abbott India remains a stock with potential, but one that requires careful monitoring amid ongoing market uncertainties.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
